Tech Company Financing Transactions
August Bioservices Funding Round
August Bioservices, based in Nashville, secured $65 million from Oak HC/FT and Polaris Partners.
Transaction Overview
Company Name
Announced On
12/2/2022
Transaction Type
Venture Equity
Amount
$65,000,000
Round
Series B
Investors
Oak HC/FT (Lead Investor) (Andrew Adams)
Polaris Partners (Brian Chee)
Proceeds Purpose
The company intends to use the funds to add capacity for large batch sterile pharmaceutical manufacturing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1845 Elm Hill Pike
Nashville, TN 37210
USA
Nashville, TN 37210
USA
Phone
Website
Email Address
Overview
August Bioservices today is a team of highly experienced scientists and professionals, providing a comprehensive service offering to advance drug discovery, pharmaceutical development, and clinical manufacturing for the pharmaceutical and biotechnology industries.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jenn Adams
Chief Financial Officer
Mats Bjoerkman
VP - Bus. Development
Marty Henehan
VP - Customer Service
Ryan Downey
VP - General Counsel
Ernie Martinez
VP - Human Resources
Erin Rhoades
VP - Operations
Joseph Mase
VP - Product Management
Chad Barnett
VP - R & D
Alexander Taylor
VP - Regulatory Affairs
Michael Scribner
Browse more venture capital transactions:
Prev: 12/2/2022: KreditBee venture capital transaction
Next: 12/2/2022: Endpoint Payment Solutions venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs